These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 11313172)
1. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172 [TBL] [Abstract][Full Text] [Related]
2. Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer. Aaltomaa S; Lipponen P; Tammi R; Tammi M; Viitanen J; Kankkunen JP; Kosma VM Urol Int; 2002; 69(4):266-72. PubMed ID: 12444281 [TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer. Aaltomaa S; Lipponen P; Ala-Opas M; Kosma VM Eur Urol; 2001 Feb; 39(2):138-44. PubMed ID: 11223672 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Pirinen R; Tammi R; Tammi M; Hirvikoski P; Parkkinen JJ; Johansson R; Böhm J; Hollmén S; Kosma VM Int J Cancer; 2001 Jan; 95(1):12-7. PubMed ID: 11241304 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy. Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronan expression in differentiated thyroid carcinoma. Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369 [TBL] [Abstract][Full Text] [Related]
7. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. Ghatak S; Hascall VC; Markwald RR; Misra S J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383 [TBL] [Abstract][Full Text] [Related]
9. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Karjalainen JM; Tammi RH; Tammi MI; Eskelinen MJ; Agren UM; Parkkinen JJ; Alhava EM; Kosma VM Am J Pathol; 2000 Sep; 157(3):957-65. PubMed ID: 10980134 [TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Aaltoma SH; Lipponen PK; Kosma VM Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818 [TBL] [Abstract][Full Text] [Related]
11. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. Auvinen P; Tammi R; Kosma VM; Sironen R; Soini Y; Mannermaa A; Tumelius R; Uljas E; Tammi M Int J Cancer; 2013 Feb; 132(3):531-9. PubMed ID: 22753277 [TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. Aaltomaa S; Eskelinen M; Lipponen P Prostate; 1999 Feb; 38(3):175-82. PubMed ID: 10068341 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma VM Histopathology; 2001 Jan; 38(1):13-20. PubMed ID: 11135041 [TBL] [Abstract][Full Text] [Related]
15. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome. Tidehag V; Hammarsten P; Egevad L; Granfors T; Stattin P; Leanderson T; Wikström P; Josefsson A; Hägglöf C; Bergh A Eur J Cancer; 2014 Jul; 50(10):1829-1835. PubMed ID: 24726733 [TBL] [Abstract][Full Text] [Related]
16. The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome. Masarwah A; Tammi M; Sudah M; Sutela A; Oikari S; Kosma VM; Tammi R; Vanninen R; Auvinen P Breast Cancer Res Treat; 2015 Oct; 153(3):625-34. PubMed ID: 26362804 [TBL] [Abstract][Full Text] [Related]
17. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma VM Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856 [TBL] [Abstract][Full Text] [Related]
18. Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Kosunen A; Ropponen K; Kellokoski J; Pukkila M; Virtaniemi J; Valtonen H; Kumpulainen E; Johansson R; Tammi R; Tammi M; Nuutinen J; Kosma VM Oral Oncol; 2004 Mar; 40(3):257-63. PubMed ID: 14747056 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome. Josefsson A; Adamo H; Hammarsten P; Granfors T; Stattin P; Egevad L; Laurent AE; Wikström P; Bergh A Am J Pathol; 2011 Oct; 179(4):1961-8. PubMed ID: 21854754 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Setälä LP; Tammi MI; Tammi RH; Eskelinen MJ; Lipponen PK; Agren UM; Parkkinen J; Alhava EM; Kosma VM Br J Cancer; 1999 Mar; 79(7-8):1133-8. PubMed ID: 10098747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]